Hideyo Yamaguchi

Q: What Schools Are Affiliated With Hideyo Yamaguchi

Hideyo Yamaguchi is affiliated with the following schools: Teikyo University, Chiba University, University of Tokyo, Nagasaki University

Hideyo Yamaguchi's AcademicInfluence.com Rankings

Hideyo Yamaguchi

Biology

#10547

World Rank

#13880

Historical Rank

Microbiology

#591

World Rank

#658

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Hideyo Yamaguchi Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Hideyo Yamaguchi's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Antibacterial activity of essential oils and their major constituents against respiratory tract pathogens by gaseous contact. (2001) (757)
Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital (2009) (738)
Detection of a wide range of medically important fungi by the polymerase chain reaction. (1994) (420)
Phylogenetic Classification and Species Identification of Dermatophyte Strains Based on DNA Sequences of Nuclear Ribosomal Internal Transcribed Spacer 1 Regions (1999) (243)
Malassezia nana sp. nov., a novel lipid-dependent yeast species isolated from animals. (2004) (230)
A one-enzyme PCR-RFLP assay for identification of six medically important Candida species. (2006) (225)
Screening of the antibacterial effects of a variety of essential oils on respiratory tract pathogens, using a modified dilution assay method (2001) (208)
Phylogenetic Classification of Trichophyton mentagrophytes Complex Strains Based on DNA Sequences of Nuclear Ribosomal Internal Transcribed Spacer 1 Regions (1998) (148)
A Novel Murine Model of Oral Candidiasis with Local Symptoms Characteristic of Oral Thrush (2003) (146)
A Multicenter, Open-Label Clinical Study of Micafungin (FK463) in the Treatment of Deep-seated Mycosis in Japan (2004) (144)
Complete regression of mouse mammary carcinoma with a size greater than 15 mm by frequent repeated hyperthermia using magnetite nanoparticles. (2003) (138)
Species identification and strain typing of Malassezia species stock strains and clinical isolates based on the DNA sequences of nuclear ribosomal internal transcribed spacer 1 regions. (2000) (136)
Molecular diagnosis and epidemiology of fungal infections. (1998) (135)
Comparison of different methods for extraction of mitochondrial DNA from human pathogenic yeasts. (2002) (134)
Cooperative Anti‐Candida Effects of Lactoferrin or Its Peptides in Combination with Azole Antifungal Agents (1996) (118)
Relationships between biomarkers of cartilage, bone, synovial metabolism and knee pain provide insights into the origins of pain in early knee osteoarthritis (2011) (116)
A simple PCR-RFLP method for identification and differentiation of 11 Malassezia species. (2005) (109)
New iontophoretic transdermal administration of the beta-blocker metoprolol (1986) (108)
Mode of action of clotrimazole. (1973) (105)
Oral Lactoferrin Treatment of Experimental Oral Candidiasis in Mice (2003) (104)
Killer toxin from Hansenula mrakii selectively inhibits cell wall synthesis in a sensitive yeast (1986) (101)
Inhibition of Hyphal Growth of Azole-Resistant Strains of Candida albicans by Triazole Antifungal Agents in the Presence of Lactoferrin-Related Compounds (1998) (93)
Revised Culture-Based System for Identification of Malassezia Species (2007) (92)
[Anti-Candida albicans activity of essential oils including Lemongrass (Cymbopogon citratus) oil and its component, citral]. (2003) (92)
Studies on the mechanism of antifungal action of aculeacin A. (1982) (80)
Antagonistic Action of Lipid Components of Membranes from Candida albicans and Various Other Lipids on Two Imidazole Antimycotics, Clotrimazole and Miconazole (1977) (79)
Beneficial effect of a diet containing heat‐killed Lactobacillus paracasei K71 on adult type atopic dermatitis (2011) (79)
Suppression of tumor necrosis factor-alpha-induced neutrophil adherence responses by essential oils. (2003) (77)
Suppression of neutrophil accumulation in mice by cutaneous application of geranium essential oil (2005) (76)
In vitro antifungal activity of a novel lipopeptide antifungal agent, FK463, against various fungal pathogens. (2000) (74)
Antisporulating and respiration‐inhibitory effects of essential oils on filamentous fungi (1998) (74)
In‐vitro and in‐vivo anti‐Trichophyton activity of essential oils by vapour contact (2001) (72)
Effect of Sealing and Tween 80 on the Antifungal Susceptibility Testing of Essential Oils (2001) (72)
In vitro antifungal activity of luliconazole (NND-502), a novel imidazole antifungal agent (2004) (71)
Antifungal spectrum and fungicidal mechanism of an N-terminal peptide of bovine lactoferrin (1996) (71)
Lactoferrin given in food facilitates dermatophytosis cure in guinea pig models. (2000) (70)
Differentiation of Candida albicans and Candida dubliniensis using a single-enzyme PCR-RFLP method. (2005) (69)
Augmentation of murine tumor necrosis factor production by amphotericin B in vitro and in vivo (1993) (64)
Oral intake of soy isoflavone aglycone improves the aged skin of adult women. (2007) (62)
Effects of butenafine hydrochloride, a new benzylamine derivative, on experimental dermatophytosis in guinea pigs (1990) (62)
Morphological changes of Candida albicans induced by micafungin (FK463), a water-soluble echinocandin-like lipopeptide. (2002) (61)
A novel method to estimate the contribution of the vapor activity of essential oils in agar diffusion assay. (2006) (61)
In Vitro and In Vivo Antidermatophyte Activities of NND-502, a Novel Optically Active Imidazole Antimycotic Agent (1998) (60)
In vitro antifungal activity of luliconazole against clinical isolates from patients with dermatomycoses (2006) (59)
Inhibition of protein synthesis by blasticidin S. I. Studies with cell-free systems from bacterial and mammalian cells. (1965) (58)
Effect of a dietary supplement containing glucosamine hydrochloride, chondroitin sulfate and quercetin glycosides on symptomatic knee osteoarthritis: a randomized, double-blind, placebo-controlled study. (2012) (57)
Control of dimorphism in Candida albicans by zinc: effect on cell morphology and composition. (1975) (57)
A Rapid Colorimetric Assay for Determination of Leukocyte‐Mediated Inhibition of Mycelial Growth of Candida albicans (1994) (56)
Effect of orally administered bovine lactoferrin on the immune response in the oral candidiasis murine model. (2004) (56)
Suppression of neutrophil recruitment in mice by geranium essential oil. (2004) (54)
Inhibition of protein synthesis by blasticidin S. II. Studies on the site of action in E. coli polypeptide synthesizing systems. (1966) (54)
Histopathology of experimental invasive pulmonary aspergillosis in rats: pathological comparison of pulmonary lesions induced by specific virulent factor deficient mutants. (1999) (53)
Mechanisms of fluconazole resistance in Candida albicans isolates from Japanese AIDS patients. (2001) (52)
In vitro antifungal activity of posaconazole against various pathogenic fungi. (2001) (52)
Immunomodulating Activity of Antifungal Drugs (1993) (50)
Effect of Fatty Acyl Group and Sterol Composition on Sensitivity of Lecithin Liposomes to Imidazole Antimycotics (1979) (47)
Protective activity of geranium oil and its component, geraniol, in combination with vaginal washing against vaginal candidiasis in mice. (2008) (46)
Effect of Aculeacin A, a Wall‐Active Antibiotic, on Synthesis of the Yeast Cell Wall (1985) (46)
Purification and Characterization of Secretory Proteinase of Candida albicans (1992) (45)
Mortality of Candida albicans-infected mice is facilitated by superinfection of Escherichia coli or administration of its lipopolysaccharide. (1995) (45)
Electron microscopic studies on the mechanism of action of clotrimazole on Canada albicans (1973) (43)
Augmented inhibition of growth of Candida albicans by neutrophils in the presence of lactoferrin. (1997) (43)
Short-Term Therapy with Luliconazole, a Novel Topical Antifungal Imidazole, in Guinea Pig Models of Tinea Corporis and Tinea Pedis (2012) (42)
In vitro activity of the killer toxin from yeast Hansenula mrakii against yeasts and molds. (1988) (42)
In Vitro Antifungal Activity of KP-103, a Novel Triazole Derivative, and Its Therapeutic Efficacy against Experimental Plantar Tinea Pedis and Cutaneous Candidiasis in Guinea Pigs (2001) (41)
Mechanism of kasugamycin action on polypeptide synthesis. (1966) (41)
Suppression of Anti‐Candida Activity of Murine Neutrophils by Progesterone In Vitro: A Possible Mechanism in Pregnant Women's Vulnerability to Vaginal Candidiasis (1995) (40)
Mechanism of action of phleomycin, a tumor-inhibitory antibiotic. (1963) (40)
Effects of micafungin on the morphology of Aspergillus fumigatus. (2005) (40)
Usefulness of a colorimetric method for testing antifungal drug susceptibilities of Aspergillus species to voriconazole (2002) (39)
PCR identification system for the genus Aspergillus and three major pathogenic species: Aspergillus fumigatus, Aspergillus flavus and Aspergillus niger. (2004) (39)
Fungal Flora on Board the Mir‐Space Station, Identification by Morphological Features and Ribosomal DNA Sequences (2001) (38)
Protection by unsaturated lecithin against the imidazole antimycotics, clotrimazole and miconazole (1978) (38)
A novel model of cutaneous candidiasis produced in prednisolone-treated guinea-pigs. (1994) (38)
Mode of action of 6-cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridone ethanolamine salt (Hoe 296). (1978) (36)
Potential of Ravuconazole and its Prodrugs as the New OralTherapeutics for Onychomycosis. (2016) (36)
RI‐331, a New Antifungal Antibiotic (1988) (36)
[Antifungal drug]. (2003) (36)
Achievement of Complete Mycological Cure by Topical Antifungal Agent NND‐502 in Guinea Pig Model of Tinea Pedis (2003) (35)
Suppression of Carrageenan- and Collagen II-Induced Inflammation in Mice by Geranium Oil (2006) (35)
In vitro studies of a new imidazole antimycotic, bifonazole, in comparison with clotrimazole and miconazole. (1983) (35)
Two mechanisms of butenafine action in Candida albicans (1993) (35)
The mechanism of antifungal action of (S)-2-amino-4-oxo-5-hydroxypentanoic acid, RI-331: the inhibition of homoserine dehydrogenase in Saccharomyces cerevisiae. (1990) (34)
Protection of C3H/HE J mice from development of Candida albicans infection by oral administration of Juzen-taiho-to and its component, Ginseng radix: possible roles of macrophages in the host defense mechanisms. (1996) (34)
Inhibition of Candida albicans Growth by Murine Peritoneal Neutrophils and Augmentation of the Inhibitory Activity by Bacterial Lipopolysaccharide and Cytokines (1994) (34)
In vitro activity of novel imidazole antifungal agent NND-502 against Malassezia species. (2003) (34)
Prophylactic Effect of Enterococcus faecalis FK‐23 Preparation on Experimental Candidiasis in Mice (1996) (33)
Evaluation of the effect of glucosamine administration on biomarkers for cartilage and bone metabolism in soccer players. (2009) (33)
Volatile Aroma Constituents of Three Labiatae Herbs Growing Wild in the Karakoram-Himalaya District and Their Antifungal Activity by Vapor Contact (2001) (33)
The vapor activity of oregano, perilla, tea tree, lavender, clove, and geranium oils against a Trichophyton mentagrophytes in a closed box (2006) (33)
A comparative clinical study between 2 weeks of luliconazole 1% cream treatment and 4 weeks of bifonazole 1% cream treatment for tinea pedis (2006) (33)
Granulocyte-colony stimulating factor facilitates the restoration of resistance to opportunistic fungi in leukopenic mice. (1992) (32)
Tween 40-based precipitate production observed on modified chromogenic agar and development of biological identification kit for Malassezia species. (2006) (32)
Anti-Tumor Activities of the Antlered Form of Ganoderma lucidum in Allogeneic and Syngeneic Tumor-Bearing Mice (2006) (32)
Therapeutic effects on murine oral candidiasis by oral administration of cassia (Cinnamomum cassia) preparation. (2010) (31)
In-situ detection of Aspergillus fumigatus. (2000) (31)
Vital growth factors of Malassezia species on modified CHROMagar Candida. (2005) (31)
Efficient coating of the solid phase with rotavirus antigens for enzyme-linked immunosorbent assay of immunoglobulin A antibody in feces (1984) (31)
Evaluation of the effect of terpenoid quinones on Trichophyton mentagrophytes by solution and vapor contact (2006) (31)
ISOLATION AND CHARACTERIZATION OF MICROBODIES FROM CANDIDA TROPICALIS PK 233 CELLS GROWN ON NORMAL ALKANES (1975) (31)
Therapeutic Efficacy of Human Macrophage Colony-Stimulating Factor, Used Alone and in Combination with Antifungal Agents, in Mice with Systemic Candida albicans Infection (2000) (30)
A Novel Mechanism of Fluconazole Resistance Associated with Fluconazole Sequestration in Candida albicans Isolates from a Myelofibrosis Patient (2002) (30)
In-vitro studies of a new oral azole antimycotic, BAY N 7133. (1983) (30)
Specific detection of Aspergillus and Penicillium species from respiratory specimens by polymerase chain reaction (PCR). (1994) (30)
Mycelial development and chemical alteration of Candida albicans from biotin insufficiency. (1974) (29)
Effect of a glucosamine-based combination supplement containing chondroitin sulfate and antioxidant micronutrients in subjects with symptomatic knee osteoarthritis: A pilot study. (2011) (29)
In vitro studies of aculeacin A, a new antifungal antibiotic. (1982) (29)
[In vitro activity of fluconazole, a novel bistriazole antifungal agent]. (1989) (29)
Cluster Analysis of Human and Animal Pathogenic Microsporum Species and Their Teleomorphic States, Arthroderma Species, Based on the DNA Sequences of Nuclear Ribosomal Internal Transcribed Spacer 1 (2001) (28)
In Vitro and In Vivo Activities of CS-758 (R-120758), a New Triazole Antifungal Agent (2002) (28)
Characterization of Mechanisms of Fluconazole Resistance in a Candida albicans Isolate from a Japanese Patient with Chronic Mucocutaneous Candidiasis (2004) (28)
Efficacy of Luliconazole Against Broad-Range Filamentous Fungi Including Fusarium solani Species Complex Causing Fungal Keratitis (2018) (28)
Topical treatment with butenafine significantly lowers relapse rate in an interdigital tinea pedis model in guinea pigs (1992) (28)
Effect of lactoferrin feeding on the host antifungal response in guinea-pigs infected or immunised with Trichophyton mentagrophytes. (2002) (27)
Protective effect of oral administration of a traditional medicine, Juzen-Taiho-To, and its components on lethal Candida albicans infection in immunosuppressed mice. (1998) (27)
Combined effect of heat, essential oils and salt on fungicidal activity against Trichophyton mentagrophytes in a foot bath. (2007) (27)
Suppression of Anti‐Candida Activity of Murine and Human Neutrophils by Glucocorticoids (1994) (27)
Studies on the Affinity of Terbinafine with Keratine (1993) (26)
Changes in Visceral Adiposity and Serum Cholesterol with a Novel Viscous Polysaccharide in Japanese Adults with Abdominal Obesity (2013) (26)
Effect of a traditional Japanese garlic preparation on blood pressure in prehypertensive and mildly hypertensive adults (2012) (26)
Binding of benanomicin A to fungal cells in reference to its fungicidal action. (1996) (26)
Natural pathogens of laboratory animals and their effects on research. (2000) (26)
Invasion process of Candida albicans to tongue surface in early stages of experimental murine oral candidiasis. (2008) (26)
Enhancement by ubenimex (bestatin) of host resistance to Candida albicans infection. (1992) (26)
Antifungal activity of the new agent latoconazole in two tinea models. (1991) (26)
Partial Sequences of Large Subunit Ribosomal DNA of a New Yeast Species, Trichosporon domesticum and Related Species (1997) (25)
EFFECT OF BIOTIN INSUFFICIENCY ON COMPOSITION AND ULTRASTRUCTURE OF CELL WALL OF CANDIDA ALBICANS IN RELATION TO ITS MYCELIAL MORPHOGENESIS (1974) (25)
Protection of oral or intestinal candidiasis in mice by oral or intragastric administration of herbal food, clove (Syzygium aromaticum). (2005) (25)
Molecular Biology and its Application to Medical Mycology (2012) (25)
Once daily administration of terbinafine to guinea‐pigs with experimental dermatophytosis (1989) (25)
Therapeutic efficacy of lanoconazole, a new imidazole antimycotic agent, for experimental cutaneous candidiasis in guinea pigs (1994) (24)
Reproducible genetic transformation system for two dermatophytes, Microsporum canis and Trichophyton mentagrophytes. (2005) (23)
In Vitro Antifungal Synergism between Pyrrolnitrin and Clotrimazole (1989) (23)
Dose‐finding comparative study of 2 weeks of luliconazole cream treatment for tinea pedis – comparison between three groups (1%, 0.5%, 0.1%) by a multi‐center randomised double‐blind study (2007) (23)
Rapid identification of Trichophyton tonsurans by specific PCR based on DNA sequences of nuclear ribosomal internal transcribed spacer (ITS) 1 region. (2006) (23)
The effect of bifonazole on the structure of Trichophyton mentagrophytes. (1984) (23)
Synergy of lysozyme and lanoconazole on the morphology of Candida albicans. (2001) (23)
Morphological changes associated with growth inhibition of Trichophyton mentagrophytes by amorolfine (1992) (22)
Efficacy of NND-502, a novel imidazole antimycotic agent, in experimental models of Candida albicans and Aspergillus fumigatus infections. (1999) (22)
Inhibition of RNA and DNA polymerase reactions by pluramycin A. (1965) (22)
Protection of immunosuppressed mice from lethal Candida infection by oral administration of a kampo medicine, hochu-ekki-to. (1999) (22)
In vivo activity of bifonazole in guinea pigs: its characteristic features and comparison with clotrimazole. (1984) (22)
Protective effects of human saliva on experimental murine oral candidiasis (2004) (22)
The mode of antifungal action of (S)2-amino-4-oxo-5-hydroxypentanoic acid, RI-331. (1990) (22)
Anamnestic response in fecal IgA antibody production after rotaviral infection of infants. (1985) (21)
Electron microscopic studies on the mechanism of action of clotrimazole on Candida albicans. (1973) (21)
Immunohistochemical diagnosis of Cryptococcus neoformans var. gattii infection in chronic meningoencephalitis: the first case in Japan. (2001) (21)
Short-term topical therapy of experimental tinea pedis in guinea pigs with lanoconazole, a new imidazole antimycotic agent (1995) (21)
Enhanced anti-Candida activity of neutrophils and azole antifungal agents in the presence of lactoferrin-related compounds. (1998) (21)
Correlation between serum thymus and activation-regulated chemokine levels and stratum corneum barrier function in healthy individuals and patients with mild atopic dermatitis. (2012) (20)
Reduced activity of Candida detachment factors in the saliva of the elderly (2004) (20)
Histopathological study on experimental endophthalmitis induced by bloodstream infection with Candida albicans. (2007) (20)
Inhibition of polypeptide synthesis by kasugamycin, an aminoglycosidic antibiotic. (1966) (20)
Inhibition of sterol 14 alpha-demethylation of Candida albicans with NND-502, a novel optically active imidazole antimycotic agent. (1999) (20)
Proliferation of Intracellular Structure Corresponding to Reduced Affinity of Fluconazole for Cytochrome P‐450 in Two Low‐Susceptibility Strains of Candida albicans Isolated from a Japanese AIDS Patient (2003) (20)
A case of pulmonary aspergilloma molecular biological identification and typing of the isolates from antemortem sputa and autopsy fungus ball (2003) (20)
Evaluation of the effects of a supplementary diet containing chicken comb extract on symptoms and cartilage metabolism in patients with knee osteoarthritis. (2010) (19)
Anti‐Candida Activity of Cal protect in in Combination with Neutrophils or Lactoferrin (1998) (19)
Karyotyping by PFGE of clinical isolates of Sporothrix schenckii. (1996) (19)
Acidic polysaccharides from rhizomes of Atractylodes lancea as protective principle in Candida-lnfected mice. (2001) (18)
Effect of acacia polyphenol on glucose homeostasis in subjects with impaired glucose tolerance: A randomized multicenter feeding trial (2013) (18)
Beneficial Effect of Honeybee-collected Pollen Lump Extract on Benign Prostatic Hyperplasia (BPH) — A Double-blind, Placebo-controlled Clinical Trial — (2008) (18)
Studies on uptake of 6-cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridone ethanolamine salt (Hoe 296) by Candida albicans. (1978) (18)
The Molecular Identification and Antifungal Susceptibilities of Aspergillus Species Causing Otomycosis in Tochigi, Japan (2018) (18)
Electronmicroscopical studies on the fungitoxicity of bisphenyl-(2-chlorophenyl)-1-imidazolyl methane (BAY b 5097): preferential effect on the nuclear envelope in Candida albicans cells. (1973) (18)
Characteristic biological effects of itraconazole on L929 fibroblasts and their cell membrane (2000) (18)
Evaluation of In Vitro Antimycotic Activity of Terbinafine, a New Allylamine Agents (1991) (17)
Development of Reference Procedures for Broth Microdilution Antifungal Susceptibility Testing of Yeasts with Standardized Endpoint Determination (1998) (17)
Macromolecular Structure and Morphology of Native Glycogen Particles Isolated from Candida albicans (1974) (17)
Mechanism of action of an antifungal antibiotic, RI-331, (S) 2-amino-4-oxo-5-hydroxypentanoic acid; kinetics of inactivation of homoserine dehydrogenase from Saccharomyces cerevisiae. (1992) (17)
Effects of butenafine hydrochloride, a new benzylamine derivative, on experimental tinea pedis in guinea pigs (1990) (16)
The in-vivo activity of an antifungal antibiotic, benanomicin A, in comparison with amphotericin B and fluconazole. (1997) (16)
Morphological Detection of Filipin‐Sterol Complexes in the Cytoplasmic Membrane of Staphylococcal L‐Form (1990) (16)
Mechanism of action of kasugamycin. (1965) (16)
Selected animal models: vaginal candidosis, Pneumocystis pneumonia, dermatophytosis and trichosporosis. (1998) (16)
Effect of Aculeacin A on Reverting Protoplasts of Candida albicans (1987) (16)
Comparison of the therapeutic efficacy of oral doses of fluconazole and itraconazole in a guinea pig model of dermatophytosis (2000) (16)
A Queensland koala kept in a Japanese zoological park was carrier of an imported fungal pathogen, Filobasidiella neoformans var. bacillispora (Cryptococcus neoformans var. gattii). (2002) (16)
Unique mechanism of action of an antifungal antibiotic RI-331. (1988) (16)
Augmented inhibition of Candida albicans growth by murine neutrophils in the presence of a tryptophan metabolite, picolinic acid (2004) (16)
Detachment activity of human saliva in vitro for Candida albicans cells attached to a plastic plate (2003) (15)
Selective Toxicity of Mikamycins, Inhibitors of Protein Synthesis (1964) (15)
Experimental disseminated trichosporonosis in mice: tissue distribution and therapy with antifungal agents. (1997) (15)
Development of a New Medium Useful for the Recovery of Dermatophytes from Clinical Specimens by Minimizing the Carryover Effect of Antifungal Agents (2002) (15)
Comparison of the in vitro activity of terbinafine and lanoconazole against dermatophytes (2009) (15)
How Histopathology Can Contribute to an Understanding of Defense Mechanisms against Cryptococci (2013) (14)
[Activity of Enterococcus faecalis (FK-23) preparation as a biological response modifier]. (1992) (14)
Bleomycin hydrolase is a unique thiol aminopeptidase. (1989) (14)
The in-vitro activity of an antifungal antibiotic benanomicin A in comparison with amphotericin B. (1996) (13)
[Studies on the mechanism of antifungal action of ciclopiroxolamine/Inhibition of transmembrane transport of amino acid, K+ and phosphate in Candida albicans cells (author's transl)]. (1981) (13)
Therapeutic effects of omoconazole nitrate on experimental tinea pedis, an intractable dermatophytosis, in guinea-pigs. (1997) (13)
Antitumor activity of trienomycin A on murine tumors. (1987) (13)
Therapeutic efficacy of latoconazole in formulations of clinical use on experimental dermatophytosis in guinea pigs. (1992) (13)
Studies on the antifungal activity of the new imidazole antimycotic lanoconazole in infected sites. Distribution in the skin and in vitro activity in the presence of stratum corneum. (1997) (13)
Oral administration of itraconazole solution has superior efficacy in experimental oral and oesophageal candidiasis in mice than its intragastric administration. (2006) (13)
KP‐103, a Novel Triazole Derivative, Is Effective in Preventing Relapse and Successfully Treating Experimental Interdigital Tinea Pedis and Tinea Corporis in Guinea Pigs (2002) (13)
Inhibition of protein synthesis by bottromycin A2 and its hydrazide. (1966) (13)
Mode of antifungal action of benanomicin A in Saccharomyces cerevisiae. (1997) (13)
Preferential percutaneous absorption of monoterpene hydrocarbons and ester of essential oils in mice placed in aroma bath and alteration of compositions of essential oils. (2000) (13)
[A study on effectiveness of treatment and prevention of relapse using topical administration of terbinafine in a guinea pig model for tinea pedis]. (1994) (13)
Ultrastructure of Saccharomyces cerevisiae treated with econazole. (1981) (12)
Optimal dose of enterococcal preparation (FK-23) supplemented perorally for stimulation of leukocyte reconstitution in dogs treated with cyclophosphamide. (1996) (12)
Comparison of Secretory Acid Proteinases from Candida tropicalis, C. parapsilosis and C. albicans (1992) (12)
Protection of Mice from Lethal Endogenous Candida albicans Infection by Immunization with Candida Membrane Antigen (2002) (12)
cDNA Cloning of an Aspartic Proteinase Secreted by Candida albicans (1992) (12)
[The therapeutic effects of itraconazole, a new triazole antifungal agent, for experimental fungal infections]. (1991) (12)
Comparison of the therapeutic efficacy of oral doses of fluconazole and griseofulvin in a guinea pig model of dermatophytosis. (2000) (12)
An epidemiological and clinical study of untreated patients with tinea pedis within a company in Japan (2003) (12)
Effect of orally administered heat-killed Enterococcus Faecalis FK-23 preparation on neutropenia in dogs treated with cyclophosphamide. (1996) (12)
Therapeutic effects of omoconazole nitrate on guinea-pigs experimentally infected with Trichophyton mentagrophytes. (1997) (11)
Anti-tumour activity of low-toxicity lipopolysaccharide of Bordetella pertussis. (1994) (11)
A glucocorticoid antagonist, mifepristone affects anti-Candida activity of murine neutrophils in the presence of prednisolone in vitro and experimental candidiasis of prednisolone-treated mice in vivo. (1996) (11)
A novel mycological analysis valuable for evaluating therapeutic efficacy of antimycotics against experimental dermatophytosis in guinea pigs (2005) (11)
An ATP Bioluminescence Assay Applicable to Rapid Fluconazole Susceptibility Testing of Dermatophytes (1997) (11)
Interaction of oxyimino beta-lactams with a class C beta-lactamase and a mutant with a spectrum extended to beta-lactams (1994) (11)
[Prophylactic efficacy of a basidiomycetes preparation AHCC against lethal opportunistic infections in mice]. (2000) (11)
Phylogenetic relationships among medically important yeasts based on sequences of mitochondrial large subunit ribosomal RNA gene (2004) (11)
Efficacy of antibacterial drugs in mice with complex infection by Candida albicans and Escherichia coli. (1999) (11)
DNA Base Alignment and Taxonomic Study of Genus Malassezia Based upon Partial Sequences of Mitochondrial Large Subunit Ribosomal RNA Gene (2003) (11)
Potential usefulness of bovine lactoferrin for adjunctive immunotherapy for mucosal Candida infections (2004) (10)
Ultrastructural Changes Induced by Terbinafine, a New Antifungal Agent, in Trichophyton mentagrophytes (1991) (10)
Attributes of microorganisms that contribute to recurrence and intractability of vaginal mycosis. (1986) (10)
Effect of orally administered heat-killed Enterococcus faecalis FK-23 preparation on leukopenia in mice treated with cyclophosphamide. (1994) (10)
Antitumor and Antimicrobial Activities of Enterococcal Preparation Orally Administered to Mice (1993) (10)
The Postantifungal Effect (PAFE) of Itraconazole, in Comparison with Those of Miconazole and Fluconazole, on Candida Species (2006) (10)
Ultrastructural Alterations of Candida albicans Induced by a New Imidazole Antimycotic Omoconazole Nitrate (1997) (10)
Efficacy of intravenous itraconazole against invasive pulmonary aspergillosis in neutropenic mice. (2006) (10)
Electron Microscopic Study on Phagocytosis of Staphylococci by Mouse Peritoneal Macrophages (1978) (10)
Biological properties of streptonigrin derivatives. III. In vitro and in vivo antiviral and antitumor activities. (1989) (10)
Assessment of in vivo activity of bifonazole against dermatophytic infection in guinea pigs on the basis of the amount of a specific fungal cell wall component chitin in the infected skin. (1984) (10)
Comparative Evaluation of Standard Dilution Method and Commercial Kit for Frozen Plate Antifungal Susceptibility Testing of Yeasts Using 200 Clinical Isolates (2004) (10)
DIMORPHISM IN CANDIDA ALBICANS . II. COMPARISON OF FINE STRUCTURE OF YEAST-LIKE AND FILAMENTOUS PHASE GROWTH (1974) (10)
Characterization of Immunological Activity of a Low Toxicity Antitumor Lipopolysaccharide from Bordetella pertussis (1994) (9)
In Vivo Fungicidal Effect of KP‐103 in a Guinea Pig Model of Interdigital Tinea Pedis Determined by Using a New Method for Removing the Antimycotic Carryover Effect (2002) (9)
[Therapeutic efficacy of a topical tolnaftate preparation in guinea pig model of tinea pedis]. (2001) (9)
Fungal peritonitis associated with Curvularia geniculata and Pithomyces species in a patient with vulvar cancer who was successfully treated with oral voriconazole (2013) (9)
[Antitumor activity of Enterococcus faecalis FK-23 preparation against murine syngeneic tumors]. (1993) (9)
Effect of two imidazole antimycotics, clotrimazole and miconazole on amino acid transport in Candida albicans. (1979) (9)
Systemic absorption and metabolism of essential oils in rats by holistic vapor exposure. (2000) (9)
Preclinical Therapeutic Evaluation of Agents for Treating Dermatophytosis (1996) (9)
Effect of a dietary supplement containing kurozu (a Japanese traditional health drink) concentrate on several obesity-related parameters in obese Japanese adults: a randomized, double-blind, placebo-controlled trial (2013) (9)
[Protective effect of oral administration of several traditional Kampo-medicines on lethal Candida infection in immunosuppressed mice]. (2000) (9)
Efficacy of CS-758, a Novel Triazole, against Experimental Fluconazole-Resistant Oropharyngeal Candidiasis in Mice (2003) (9)
Phylogenetic Classification of Trichophyton mentagrophytes Complex Strains Based on DNA Sequences of Nuclear Ribosomal Internal Transcribed Spacer 1 Regions (1998) (9)
[Therapeutic effect of amorolfine on experimental dermatophytosis]. (1991) (9)
Study of the Effective Dose of a Topical Antifungal Agent, Omoconazole Nitrate, on the Basis of Percutaneous Pharmacokinetics in Guinea‐pigs and Mice (1997) (8)
Resorthiomycin, a novel antitumor antibiotic. III. Potentiation of antitumor drugs and its mechanism of action. (1990) (8)
Biochemical properties of mitochondria from Candida albicans. (1971) (8)
Fungal Terpenoid Antibiotics and Enzyme Inhibitors (2003) (8)
The effect of bifonazole on the structure of Trichophyton. (1983) (8)
Resorthiomycin, a novel antitumor antibiotic. I. Taxonomy, isolation and biological activity. (1990) (8)
[A Case of central venous catheter-related infection with Malassezia sympodialis]. (2001) (7)
Morphological effects of itraconazole on murine macrophage. (1998) (7)
Mechanism of Action of Clotrimazole (1973) (7)
Wound healing effect of the new imidazole antimycotic lanoconazole in rats. (1996) (7)
Augmentation of production of TNF-alpha and anti-tumour activity by an amphotericin B preparation for clinical use in mice. (1997) (7)
[Host defense mechanisms against fungal infections]. (2000) (7)
In vitro an in vivo protein synthesis in Candida albicans. I. Isolation and protein synthesis of polysomes. (1970) (7)
The novel immunostimulant N-563, an analogue of deoxyspergualin, promotes resistance to Candida albicans infection in mice. (1994) (7)
Molecular and biochemical mechanisms of drug resistance in fungi. (1999) (7)
Ubiquinone system and DNA base composition of strains in the genus Malassezia determined by high-performance liquid chromatography (1992) (7)
[In vitro antifungal activities of amorolfine against fresh isolates from patients with cutaneous mycosis]. (1991) (7)
Vascular effects and safety of supplementation with shark liver oil in middle-aged and elderly males. (2015) (7)
RESORTHIOMYCIN, A NOVEL ANTITUMOR ANTIBIOTIC (1990) (6)
Therapeutic Efficacy of Oral Administration of Terbinafine in Guinea Pig Trichophytosis Model (1993) (6)
Systemic absorption of essential oils in mice by holistic vapor exposure. (2000) (6)
Therapeutic Efficacy of Terbinafine Creams, a New Allylamine Antimycotic, in Guinea Pig Dermatophytosis Model (1991) (6)
[Mechanisl of action of clotrimazole. 2. Effects on the cell membrane of Candida albicans]. (1974) (6)
[Studies on the in vitro antifungal activity of lanoconazole, a new topical antimycotic, against Trichophyton spp]. (1995) (6)
Modulation of the human interleukin-12p40 response by a triazole antifungal derivative, Itraconazole (2004) (6)
Augmentation by lactoferrin of host defense against Candida infection in mice. (2000) (6)
Studies on In Vitro Antimicrobial Activity of Miconazole (1978) (6)
[Susceptibility to miconazole (base) of isolates from the oral cavity and esophagus of patients with mycosis]. (1991) (6)
A Murine Model of Esophageal Candidiasis with Local Characteristic Symptoms (2007) (6)
[Prophylactic efficacy of a basidiomycetes preparation AHCC against lethal Candida albicans infection in experimental granulocytopenic mice]. (2003) (6)
Overview of micafungin (MCFG) (2002) (6)
Evaluation of Risk and Benefit of Oral Immunomodulation using Heat-killed Enterococcus Faecalis FK-23 Preparation in Healthy Dogs (1999) (6)
Revised structure of resorthiomycin. (1991) (6)
Effect of NND-318 on the Ultrastructure of Trichophyton mentagrophytes as Observed by Scanning and Transmission Electron Microscopy (1991) (5)
Resorthiomycin, a novel antitumor antibiotic. II. Physico-chemical properties and structure elucidation. (1990) (5)
[In vitro antifungal activity of itraconazole, a new triazole antifungal agent, against clinical isolates from patients with dermatomycoses]. (1991) (5)
Preventive Effects of Juzen-taiho-to on Infectious Diseases (2005) (5)
Inhibition by mikamycins of polypeptide synthesis directed by native messengers and synthetic polynucleotides. (1966) (5)
Morphological Alterations of Saccharomyces cerevisiae Induced by Benanomicin A, an Antifungal Antibiotic with Mannan Affinity (1998) (5)
[In vitro antifungal activity of ravuconazole against isolates of dermatophytes and Candida species from patients with dermatomycoses]. (2014) (5)
A novel murine model of pharyngeal candidiasis with local symptoms characteristic of pharyngeal thrush produced by using an inhaled corticosteroid. (2007) (5)
Isolation and Characterization of Mutants, Especially Respiratory-deficient Mutants, of Candida albicans (1982) (5)
In vitro and in vivo protein synthesis in Candida albicans. 3. Protein synthesis and inhibition. (1970) (5)
Effective Inhibition of Candida albicans Growth by the Combination of Murine Peritoneal Neutrophils and Activated Macrophages (1999) (5)
Evaluation of the effect of a chicken comb extract-containing supplement on cartilage and bone metabolism in athletes (2012) (5)
Improvement of liver function by the administration of oyster extract as a dietary supplement to habitual alcohol drinkers: A pilot study. (2015) (5)
[Therapeutic efficacy of lanoconazole ointment in guinea pig model of tinea corporis, a comparative study with ointment and cream preparations]. (1995) (5)
Mechanism of action of antimycotics. (1980) (5)
In vitro activity of ME1401, a new antifungal agent (1986) (5)
Production of anti-Candida antibodies in mice with gut colonization of Candida albicans. (2004) (5)
Effect of Oral Administration of Heat‐Killed Enterococcus faecalis FK‐23 on the Leukocyte‐Reconstituting Capacity in Immunosuppressed Dogs (1993) (5)
Studies on Antifungal Mechanism of Action of Butenafine Hydrochloride (1991) (5)
[Retention of amorolfine in the skin tissue as measured by prevention of the development of experimental dermatophytosis in guinea pigs]. (1991) (4)
Biological studies on mikamycin. IV. Blood and tissue levels of tritiated mikamycins A and B. (1962) (4)
Isolation of a promoter region of a secreted metalloprotease gene from Microsporum canis. (2004) (4)
[Effectiveness of oral treatment with terbinafine in a guinea pig model of tinea pedis]. (1994) (4)
[Therapeutic efficacy of lanoconazole ointment in guinea pig model of tinea pedis, in comparison with that of cream preparations]. (1994) (4)
In vitro Antifungal Activity of SS717, a New Imidazole Antimycotic (1990) (4)
[In vitro susceptibility to fluconazole of fungal strains freshly isolated from child patients with deep-seated mycoses]. (1993) (4)
Correlation of in vitro activity and in vivo efficacy of itraconazole intravenous and oral solubilized formulations by testing Candida strains with various itraconazole susceptibilities in a murine invasive infection. (2011) (4)
Butenafine, a New Benzylamine Derivative: In vitro Effect on Arthrospores of T. mentagrophytes and Therapeutic Efficacy on Experimental Tinea Pedis in Guinea pigs (1992) (4)
In vitro Anti-Malassezia Activity of Terbinafine (1991) (4)
In vitro and In vivo protein synthesis in Candida albicans (2009) (4)
[Drug properties of fosravuconazole L-lysine ethanolate (NAILIN® Capsules 100 mg), a new oral azole therapeutic for onychomycosis: an analysis based on non-clinical and clinical trial data]. (2019) (4)
[Advances in serological systems for diagnosis of systemic fungal infections, particularly those caused by Candida and Aspergillus]. (2002) (4)
Anti-Candida Activity of Clotrimazole in Combination with Dioctyl Sodium Sulfosuccinate and Other Surfactants (1977) (4)
Species distribution and in vitro susceptibility to three antifungal triazoles of clinical Candida isolates from a five-year nation-wide survey in Japan (2012) (4)
[Suppressive effect of lansoprazole on anti-Candida activity of murine macrophages]. (2001) (4)
Therapeutic Efficacy of Oral Treatment with a Traditional Medicine, Juzen-taiho-to against Experimental Deep-seated Mycoses in Mice (1995) (4)
In vitro and in vivo antifungal activities of FX0685, a novel triazole antifungal agent with potent activity against fluconazole-resistant Candida albicans. (2005) (4)
Mechanism of Action of Antifungal Agents (1983) (4)
[In vitro antifungal activity of omoconazole nitrate, a new imidazole antimycotic]. (1993) (4)
Roles of Activated Macrophages in Host Defense Mechanisms Against Candida Infection (1997) (4)
Metalloprotease gene of Arthroderma gypseum. (2005) (4)
Blood Lysate Staining, a New Microscopic Method for Diagnosis of Fungemia Using Peripheral Blood (2000) (4)
Effect of Amorolfine, a New Antifungal Agent, on the Ultrastructure of Trichophyton mentagrophytes (1991) (3)
Prophylactic Effect of NND-318, a New Antimycotic, on Experimental Dermatophytosis in Guinea Pigs (1992) (3)
Correlation between antifungal activity and hydrophobicity of imidazole antifungal agents. (1997) (3)
In vitro Antifungal Activity of NND-318, a New Antimycotic (1992) (3)
[In vitro antifungal activity of amorolfine, a new morpholine antimycotic agent]. (1991) (3)
In vivo activity and metabolic fate of 2-(2,3,3-triiodoallyl)tetrazole (ME1401), a novel antifungal agent. (1989) (3)
In vitro and in vivo anti-Candida albicans activities of butenafine hydrochloride. (1991) (3)
Intracellular degradation of bleomycin hydrolase in two Chinese hamster cell lines in relation to their peplomycin susceptibility. (1989) (3)
Protective effect of bilberry-derived anthocyanins-containing diet on VDT work-induced subjective asthenopic symptoms and the accomodative eye function impairment in healthy adults (2013) (3)
Effect of Synthesized Inulin on Bowel Habit and Fecal Microflora in Healthy Adults with Low Fecal Frequency (2010) (3)
Safety of an Acacia polyphenol dietary supplement: Safety evaluation studies in healthy male adults (2011) (3)
Studies on the Mechanism of Action of Econazole (1979) (3)
Increases in Production of Tumor Necrosis Factor in Germ-Free Mice Fed Enterococcus faecalis FK-23 Preparation (1995) (3)
Prophylactic Effects of Novel Allylamine Terbinafine Against Clinical Onset of Fungal Infection: An Experiment in Guinea Pigs Infected with Trichophyton mentagrophytes (1993) (3)
[Cross-resistance of Candida albicans to several different families of antifungals with ergosterol biosynthesis-inhibiting activity]. (1994) (3)
Suppression of macrophage activation by peritoneal fluid from patients with endometriosis. (1998) (3)
[Augmentation of anti-Candida activity of neutrophils by macrophages treated with itraconazole]. (1998) (3)
In vitro and in vivo protein synthesis in Candida albicans. 2. Dissociation properties of ribosomes. (1970) (3)
Augmentation of Anti-Candida Activity of Lanoconazole by Lysozyme (1996) (3)
Studies on the mechanism of antifungal action of a new imidazole antimycotic SS717. (1990) (3)
[The in vitro properties of a new hydroxypyridone antimycotic rilopirox, with special reference to its anti-Candida activity]. (1999) (2)
Morphological Effects of Tolciclate on the Growth of Trichophyton mentagrophytes Revealed by Scanning Electron Microscopy (1992) (2)
Clinical evaluation of orally administered bovine lactoferrin for treatment of tinea pedis. (2000) (2)
[Various factors influencing in vitro antifungal activities of omoconazole nitrate (OMZ), a new imidazole antimycotic]. (1994) (2)
BRM activities of low-toxic Bordetella pertussis lipopolysaccharides. (1992) (2)
Histopathological Study of Murine Pulmonary Cryptococcosis (1988) (2)
Subacute spinal cord infarction due to zygomycotic thrombosis in a patient with myelodysplastic syndrome. (2000) (2)
Effects of biopolymers and magnesium on the mikamycins inhibition of polyphenylalanine synthesis and the synergistic action of mikamycins A and B. (1967) (2)
Studies on the membrane-active properties of imidazole antimycotics: selective sensitivity of lecithin liposomes depending on their lipid composition. (1980) (2)
[Inhibition of mycelial growth of Candida albicans by ascites fluid of tumor bearing mice]. (1998) (2)
Effects of Itraconazole on Cell Membrane of Murine Macrophages (1996) (2)
[Status and issues of preclinical evaluation of the therapeutic effects of newly developed antifungal agents]. (2004) (2)
[Augmented ability of spleen cells to produce interferons and prevention from lethal infection of herpes simplex virus in mice orally treated with Enterococcus faecalis preparation, FK-23]. (1996) (2)
Studies on the Mode of Action of a New Imidazole Antimycotic Sulconazole (1983) (2)
Basal Studies and Preclinical Evaluations of Newly Developed Antifungal Agents (1985) (2)
MECHANISM OF ACTION OF ANGUSTMYCINS, MIKAMYCINS, AND PHLEOMYCIN. (1963) (2)
Mechanism of Antifungal Action of Terbinafine in Candida albicans Compared with That of Tolciclate (1992) (2)
[Mechanism of action of clotrimazole. I. Study of the principal action on Candida albicans]. (1973) (2)
Repression of the Capacity to Produce Tumor Necrosis Factor Alpha in Candida albicans-Infected Mice and Reversal of the Repression by Oral Juzen-taiho-to Treatment (1997) (2)
A clinical trial of voriconazole for deep-seated mycosis. An Uncontrolled Multicenter Study (2005) (2)
Mechanism of Antifungal Action of Terbinafine in Susceptible Wild and Resistant Mutant Strains of Sporothrix schenckii (1992) (2)
[Prophylactic effect of oral terbinafine on the development of infection in guinea pigs inoculated with Trichophyton mentagrophytes]. (1994) (2)
Enhancement of host resistance to opportunistic infections by ubenimex (bestatin). (1992) (2)
[Antifungal agents--recent trends in development and progress in research of action mechanism]. (1991) (2)
[In vitro antifungal activity of itraconazole, a new triazole antifungal agent, against clinical isolates from patients with systemic mycoses]. (1991) (2)
Structural Effects of Sulconazole Nitrate on the Hyphal Growth of Trichophyton rubrum (1991) (2)
Antifungal Chemotherapy with Oral Amphotericin B (1988) (2)
Secondary Cutaneous Cryptococcosis (1978) (2)
A revised culture based identification system for Malassezia 1 2 (2007) (2)
Action Mechanism of Econazole, a New Topical Imidazole Antimycotic (1981) (2)
[In vitro antifungal activity of amorolfine against Malassezia species]. (1991) (2)
Inhibition of Intracellular Bleomycin Hydrolase Activity by E‐64 Leads to the Potentiation of the Cytotoxicity of Peplomycin against Chinese Hamster Lung Cells (1989) (2)
Morphological Aspects of Antifungal Action (1993) (2)
[In vitro assay method for augmention of anti-Candida activity of murine bone marrow cells by cytokines]. (2001) (1)
Studies on mikamycins. (1963) (1)
[Therapeutic efficacies of neticonazole (SS717) cream and solution in experimental cutaneous Candida albicans infection of guinea pigs]. (1993) (1)
[Suppression of anti-Candida activity of human neutrophils by glucose and diminishment of the glucose effect by an amino acid mixture]. (1996) (1)
Inhibition of sterol 14 α-demethylation of Candida albicans with NND-502, a novel optically active imidazole antimycotic agent: Inhibition of ergosterol synthesis by NND-502 (2008) (1)
[New developments in therapy of deep mycoses]. (2000) (1)
Phase-Contrast Microscopic Studies on the Invasiveness of Aspergillus fumigatus Implanted onto the Mesenterium of Anesthetized Rats Using Cinemicrographic Technique (1993) (1)
In vitro Anti-Malassezia Activity of NND-318 (1992) (1)
Yielding ability of erect- and narrow-leaved rice mutant in heavy manuring and dense planting culture. (1979) (1)
[In vitro antifungal activity of itraconazole: a comparative study with ketoconazole]. (1991) (1)
[In vitro antifungal activity of omoconazole nitrate, a novel imidazone antimycotic drug, against clinical isolates from patients with cutaneous mycosis]. (1996) (1)
[Studies on intestinal absorption of cellular constituents of Bifidobacterium. 1. Absorption of radioactivity of (3H) leucine-labeled Bifidobacterium bifidum cells and subcellular materials in germfree and conventional mice (author's transl)]. (1980) (1)
Inhibitory Effect of NND-318 on Ergosterol Synthesis in Trichophyton mentagrophytes and Candida albicans (1992) (1)
Antifungal Drug Resistance in Mycosis (1994) (1)
Rapid-diagnosis of Deep Mycoses by PCR (1996) (1)
Yeast Strains Possessing Killer Activity against Candida albicans (1987) (1)
Scanning Electron Microscopic Study of the Effect of a New Azole Antimycotic Bifonazole on the Growth of Trichophyton mentagrophytes (1986) (1)
[Action mechanism of antifungal imidazole derivatives clotrimazole and miconazole: lipid specificity and binding sites]. (1975) (1)
[Overview of lipophilic yeast Malassezia: the current status of the molecular diagnosis]. (2002) (1)
Biological studies on mikamycin. III. Influence of blood on the activity and further investigations on the activity against experimental infections. (1962) (1)
Molecular Biological Approach to Phylogeny and Identification of Dermatophytes (1997) (1)
In vitro Antifungal Activity of NND-318, a New Imidazole Antimycotic, against Clinical Isolates from Patients with Cutaneous Mycosis (1992) (1)
Studies on action mechanism of clotrimazole as compared with other membrane-active agents and their combinations effective in synergism or antagonism (1974) (1)
In vitro and in vivo antidermatophytic effects of lactoferrin. (2000) (1)
Biological Typing of Malassezia furfur (1993) (1)
[Fundamental and clinical studies on the efficacy of bifonazole in patients with tinea pedis at 10 years after approval. Part 2. Clinical evaluation]. (1996) (1)
[Studies on the correlation of the method currently used by the Japanese Society for Medical Mycology and its modified method with the NCCLS M27-A2 microdilution method for azole susceptibility testing of Candida species]. (2006) (1)
[Taxonomy of genus Malassezia: progress and problems]. (1999) (1)
Prevalence of saliva immunoglobulin A antibodies reactive with severe acute respiratory syndrome coronavirus 2 among Japanese people unexposed to the virus (2022) (1)
[Genetic diagnosis of aspergillosis]. (1997) (1)
Simple Two-Medium System for Isolation and Identification of Candida albicans and Candida glabrata Suitable for Use with Gynecological Species (1988) (1)
Biochemical studies on the activity of thiophenicol. (1966) (1)
111 USE OF BIOMARKERS IN DISTINGUISHING PATIENTS WITH EARLY STAGE OF RADIOGRAPHIC KNEE OSTEOARTHRITIS AND KNEE PAIN (2010) (1)
[Anti-Candida activities of azole antifungals in the presence of lysozyme in vitro]. (1998) (1)
Microbiological and Histopathological Studies on Experimental Cryptococcosis in Mice (1987) (1)
[In vitro antifungal activities of lanoconazole against stock cultures and clinical isolates of Candida albicans]. (1995) (1)
Efficacy of intravenous itraconazole against invasive pulmonary aspergillosis in neutropenic mice (2006) (1)
Efficacy and safety of supplementary diet containing propolis, bee pollen, and mixed herbal extracts in management of Japanese cedar pollinosis (JCP) ─A randomized, double-blind, placebo-controlled study─ (2010) (1)
Prophylactic Effect of Enterococcus casseliflavus NF-1004 Preparation on the Lethal Infection of Mice with Opportunistic Pathogens (1996) (1)
Histochemical studies on experimental typhoid by means of fluorescein-labeled antibody. II. Cellular localization of the antigens of Salmonella enteritidis in the process of the infection of experimental typhoid. (1960) (1)
Possible mechanisms of antifungal action of an oral imidazole antimycotic ketoconazole against Candida albicans. (1985) (0)
Usefulness of a Hot-air Hand Disinfector (1999) (0)
Hansenula anomala Fungemia in a Patient with Acute Myelocytic Leukemia (1993) (0)
Antibacterial Activity of Miconazole against Aerobic and Anaerobic Bacteria (1978) (0)
The Molecular Biology of Aspartic Proteinases Secreted by Pathogenic Candida Species (1994) (0)
Yield response of an erect, narrow and thick-leaved rice mutant and the derived strain to different planting densities (1981) (0)
R106 new compounds. (1991) (0)
TwoMechanisms ofButenafine Action inCandida albicans (1993) (0)
In vitro studies on mutation frequency of 5-fluorocytosine-resistant strains of Phialophora dermatitidis (1976) (0)
[Substance produced by Staphylococcus with specific cytotoxicity to peritoneal macrophages of mice]. (1975) (0)
[New antifungal drugs and strategies in antifungal chemotherapy]. (2007) (0)
Therapeutic Efficacy of FK-936 Against Experimental Trichophyton spp. Infection in Guinea Pigs (1989) (0)
Preface (1993) (0)
Effects of Antifungal Agents in Vitro on Macrophage Morphology (1996) (0)
Immunohistological study of experimental pulmonary granulomas induced by a pathogenic yeast Cryptococus neoformans. (1990) (0)
[Immunoserodiagnosis of histoplasmosis]. (1999) (0)
Studies on the in vitro Activity of Rimoprogin, a New Synthetic Antifungal Compound (1988) (0)
Studies on Antifungal Mechanism of 5-Fluocytosine (1976) (0)
Mechanism of Action of Antifungal Chemotherapeutics (1977) (0)
Quantitative Bioassays for Miconazole with Candida albicans as the Indicator Organism (1981) (0)
Historical Perspectives and Projected Needs for Preclinical and Clinical Evaluation of Effectiveness of New Antifungal Drugs: Overview (1996) (0)
[Suppressive effects of lanoconazole on arthus phenomenon in vivo and on production and functions of TNF in vitro]. (2000) (0)
The Stadies on the Incurable Factors of the Vaginal Microsis (1987) (0)
POTENTIATION OF ANTITUMOR DRUGS AND ITS MECHANISM OF ACTION (2006) (0)
Symposium Opportunistic Fungus Infections Introduction (1986) (0)
New antimycotic susceptibility test of dermatophytes using substrate hyphae grown on low-nutrition medium as an inoculum (1992) (0)
Aspartic Proteinases Secreted by Pathogenic Candida Species (1997) (0)
[Symposium on bacterial infections in the cell]. (1971) (0)
Systemic Absorption of Miconazole after Human Intravaginal Insertion of Tablets and Antimicrobial Activity of the Drug toward Lactobacilli as Members of Normal Vaginal Flora (1981) (0)
EFFECT OF BIOTIN INSUFFICIENCY ON COMPOSI- TION AND ULTRASTRUCTURE OF CELL WALL OF CANDIDA ALBICANS IN RELATION TO ITS (2006) (0)
[Immunologic tests: Histoplasma capsulatum var. capsulatum]. (2005) (0)
Homoserine dehydrogenase as a selective target molecule for antifungal action (1993) (0)
Review of our studies on the mode of action of antifungal agents in the past two decades. (1990) (0)
Development of safety culture tube for molds and proposed procedure for collecting conidia or fixing strains to control fungal infection and allergy. (2006) (0)
Effect of RI-331, a new antifungal antibiotic, on the ultrastructure of Candida albicans (1990) (0)
[Preservation of pathogenic fungi by freezing and drying]. (1975) (0)
[Cooperative inhibitory effects of cervical mucus and neutrophils on growth of Candida albicans]. (1998) (0)
Major Topics of Basic Researches (1987) (0)
In vitro Antifungal Activity of a Novel Lipopeptide Antifungal Agent, FK463, Against Various Fungal Pathogens (2001) (0)
[In vitro antifungal activity of rilopirox, a new hydroxypyridone antimycotic agent]. (1997) (0)
[Preclinical and clinical studies on the efficacy of bifonazole in patients with tinea pedis at 10 years after approval. Part 1. Susceptibility to bifonazole of clinical isolates of dermatophytes]. (1996) (0)
Approaches to the Mechanism of Dimorphic Manifestation Using Several Morphological Mutant Strains of Candida albicans (1989) (0)
The Molecular Identification and Antifungal Susceptibilities of Aspergillus Species Causing Otomycosis in Tochigi, Japan (2018) (0)
Contents, Vol. 169, Supplement 1, 1984 (1984) (0)
[Action mechanism of Hoe 296, a new synthetic antifungal preparation]. (1975) (0)
[Pharmacological, pharmacokinetic, and clinical profile of itraconazole oral solution (ITRIZOLE Oral Solution 1%)]. (2007) (0)
Karyotyping by PFGE of clinical isolates of (1996) (0)
A survey of pathogenic Escherichia coli associated with diarrhea (1995) (0)
Recent Studies on the Mechanism of Action and the Laboratory Estimation of Antifungal Agents (1983) (0)
[Issues in the development of drugs for treating deep-seated mycosis]. (2002) (0)
Effects of Kaki (Persimmon) Extract-containing Diet on Levels of Volatile Sulfur Compounds in Oral Gas and Feces, as well as on Subjective Fecal Odor, in Healthy Adults (2014) (0)
[Molecular biological analysis of Tinea faciei caused by a clinically anomalous strain of Trichophyton mentagrophytes]. (2003) (0)
Effect of a chicken comb extract-containing supplement on subclinical joint pain in collegiate soccer players. (2012) (0)
Hay fever and the effect of influenza vaccines (2020) (0)
CAVI value during the eight-week intervention for the SLO group did not significantly differ from that for the placebo group, the changes in the CAVI value for the former group (2015) (0)
[Amoxicillin preparation with prolonged activity (author's transl)]. (1981) (0)
The Relationship between Allergic Pollinosis and Low Salivary Levels of Secretory IgA in Adults (2020) (0)
Histochemical studies on Newcastle disease virus (NDV) by fluorescent antibody technique. I. The virus antigen formation in cultured human cells. (1959) (0)
Antitumor effect of a new derivative of bleomycin against a cell line of multidrug resistant murine lymphoblastoma. (1988) (0)
Effects of lutein-containing supplement on visual acuity and vision-related quality of life in the healthy elderly with subjective visual symptoms (2014) (0)
Comparison of Flexible and Nonflexible Laparoscope (1992) (0)
Histochemical studies on experimental typhoid by means of fluorescein-labeled antibody. III. Demonstration of gamma globulin or antibody in the typhoid granuloma. (1960) (0)
[Specific and rapid identification of Malassezia species based on the DNA sequences of nuclear ribosomal internal transcribed spacer 1 regions]. (2001) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Hideyo Yamaguchi?

Hideyo Yamaguchi is affiliated with the following schools:

Hideyo Yamaguchi's Academic­Influence.com Rankings

Why Is Hideyo Yamaguchi Influential?

Hideyo Yamaguchi's Published Works

Published Works

What Schools Are Affiliated With Hideyo Yamaguchi?

Hideyo Yamaguchi's AcademicInfluence.com Rankings